Abiopharma

MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM

Investors in Baxter International, Inc. Should Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights - BAX

Nephros Launches the Nephros Water Institute to Lead National Water Safety Education

January 16, 2026 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against PRGO

Class Action Filed Against Inspire Medical Systems, Inc. (INSP) Seeking Recovery for Investors - Contact The Gross Law Firm

MoonLake Immunotherapeutics Class Action: The Gross Law Firm Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX

DEADLINE NEXT WEEK: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Contact the Firm Before December 15, 2025

Director Dillione Janet 🟡 adjusted position in 34.0K shares (2 derivative) of CorMedix Inc. (CRMD) at $12.00 Transaction Date: Dec 09, 2025 | Filing ID: 120378

Prenetics Global Ltd (PRE) Files Form 6-K

(99% Neutral) Surgery Partners, Inc. (SGRY) Files Form 8-K

Director Duey Marc 🟢 acquired 42.9K shares (1 derivative) of Aprea Therapeutics, Inc. (APRE) at $1.17 Transaction Date: Dec 10, 2025 | Filing ID: 120156

(99% Neutral) Ernexa Therapeutics Inc. (ERNA) Files Form 8-K

Hamill John P. 🟢 acquired 10.0K shares (1 derivative) of Aprea Therapeutics, Inc. (APRE) at $1.17 Transaction Date: Dec 10, 2025 | Filing ID: 120155

Baxter - Baxter Presents Real-World Data at American Society of Health System Pharmacists Meeting Demonstrating Smart Infusion Pump Electronic Medical Record (EMR) Integration May Improve Patient Safety and Nursing Bedside Productivity